Clinical Trials Browser

Phase 2 × Recruiting × Olanzapine × Clear all

NCT06995508 2026-02-17

Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT03118986 2025-10-08

RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

Phase 2 Recruiting

Nausea, Neoplasms, Vomiting